- Company Directors - D
- Dann Mitchell
Insider Trading History of Dann Mitchell
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Dann Mitchell since 2008.
The trader's CIK number is 1013102.
At the time of the last reporting, Dann Mitchell was the Interim Chief Execut of Urologix Inc. (stock ticker symbol ULGX).
Also see all insider trading activities at Urologix Inc.
Note that in the past
DANN MITCHELL also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Urologix Inc (ULGX) by Dann Mitchell
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | ULGX | 20,000 | $6,000 | 0 | $0 | 0 | $0 |
| 2012 | ULGX | 100,000 | $75,000 | 0 | $0 | 0 | $0 |
| 2008 | ULGX | 0 | $0 | 0 | $0 | 60,000 | $46,900 |
Yearly summary of insider trading at Trans1 Inc (TSON) by Dann Mitchell
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | TSON | 12,500 | $36,875 | 0 | $0 | 0 | $0 |
| 2009 | TSON | 12,500 | $49,976 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Dann Mitchell:
1. Urologix Inc (ULGX)
2. Trans1 Inc (TSON)
Table 1. Insider trading of Urologix Inc (ULGX) by Dann Mitchell
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-07-12 | ULGX | Buy | 20,000 | .30 | 6,000 |
| 2012-06-29 | ULGX | Buy | 100,000 | .75 | 75,000 |
| 2008-12-17 | ULGX | Option Ex | 10,000 | .79 | 7,900 |
| 2008-06-02 | ULGX | Option Ex | 50,000 | .78 | 39,000 |
Table 2. Insider trading of Trans1 Inc (TSON) by Dann Mitchell
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-05-27 | TSON | Buy | 12,500 | 2.95 | 36,875 |
| 2009-11-04 | TSON | Buy | 1,700 | 4.01 | 6,820 |
| 2009-11-03 | TSON | Buy | 10,800 | 4.00 | 43,156 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Dann Mitchell
(Interim Chief Execut of Urologix Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.